Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats

BACKGROUND/AIM: Treatment with growth factors could be beneficial in both inflammatory bowel disease and experimental colitis. The aim of this study was to investigate the effect of Colony Stimulating Factor (CSF), and Recombinant Human (rHu) Granulocyte Stimulating Factor (GSF) in experimental coli...

Descripción completa

Detalles Bibliográficos
Autores principales: Papalois, Apostolos E., Barbatis, Calypso, Chrysikos, Dimosthenis, Korontzi, Maria, Sideris, Michail, Pittaras, Theodoros, Triantafyllidi, Eleni, Nomikos, Alexandros, Triantafillidis, John K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803744/
https://www.ncbi.nlm.nih.gov/pubmed/31687401
http://dx.doi.org/10.1155/2019/8298192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803744/
https://www.ncbi.nlm.nih.gov/pubmed/31687401
http://dx.doi.org/10.1155/2019/8298192

Ejemplares similares